RXRA and hepatocellular carcinoma: Using anti-phosphor-Ser/Thr (p-S/T) antibody, we confirmed that GSK-3β could induce RXRα phosphorylation in HepG2 cells (Fig. 3F) and HCC tumor tissues (Fig. 3G).